Daniel W. Chan

TL;DR: In this paper, a method was developed to produce stable cell-matrix microspheres with up to 100% encapsulation efficiency and high cell viability, using matrix or biomaterial systems with poor shape and mechanical stability for applications including cell therapeutics via microinjection or surgical implantation.

TL;DR: It is shown that 43 selected N-linked glycosite-containing peptides identified in prostate cancer tissue studies carried out in the authors' group were detected in the sera of prostate cancer patients within the quantitative range of the developed PRM assays, demonstrating that the assays can be used for the high throughput and reproducible quantification of a panel of formerly N- linked glycosite - containing peptides.

TL;DR: Routine testing for both CK-MB and either of the troponins may optimize early identification of high-risk patients so they may be targeted for a higher level of care and consideration of more aggressive therapies.

TL;DR: The Elecsys CA 125 II assay is linear over a broad range, yields precise and accurate results, is free from interferences, and compares well with other assays.

TL;DR: In this article, the performance of %fPSA in differentiating benign prostate disease from CaP and to determine the CaP probability estimates using the AxSYM Free PSA and AxSYm Total PSA assays was evaluated.